- recruitingPHASE2
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
This study is testing a new medicine called IMG-007 for adults with moderate to severe eczema. Researchers want to see if it's safe and helps improve symptoms like itchy skin, compared to a dummy medicine.
United States · Canada - active not recruitingPHASE3
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
This study looks at how well a new medicine, lebrikizumab, works and if it's safe for teenagers and adults with moderate to severe eczema. It wants to see if the medicine can improve skin symptoms over 24 weeks.
Germany · Netherlands · United Kingdom - recruiting
Keep Control of Eczema Study
This study looks at the best ways to use steroid creams for eczema. It checks if specific advice on how long to use these creams helps keep eczema under control for longer. Anyone aged 1 and over in the UK who uses steroid creams for eczema can take part from home.
United Kingdom · England - recruitingPHASE3
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
This study is testing a new medicine, abrocitinib, for children aged 6 to under 12 who have moderate-to-severe eczema. We want to see if it improves their skin and is safe. Some children will get the medicine, others a pretend one.
United States · China · Germany - active not recruitingPHASE3
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
This study is looking into a new medicine called lebrikizumab for children and teenagers aged 6 months to 17 years who have moderate to severe eczema. We want to see how well it works, if it's safe, and how the body handles it.
United States · Argentina · Australia - recruiting
Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies
This study looks at how eczema affects babies' skin. Researchers use a gentle device to collect tiny skin fluid samples. They compare these samples from healthy babies and those with eczema to understand the condition better and find new ways to help prevent and treat it.
United Kingdom - active not recruitingPHASE2
Seal, Stopping Eczema and Allergy Study
This study is for babies under 12 weeks old with early eczema. It compares special skin creams and treatments to standard care to see if they can reduce eczema and prevent food allergies. We want to find the best ways to keep young skin healthy.
United States · United Kingdom - ongoing, recruitingTherapeutic confirmatory (Phase III)
J2T-MC-KGBI/DRM06-AD13: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Lebrikizumab Compared to Placebo in Participants 6 Months to <18 Years of Age with Moderate-to-Severe Atopic Dermatitis
This study is testing a new medicine called lebrikizumab for children and teenagers aged 6 months to under 18 years with moderate to severe eczema. We want to see if it helps improve their skin and is safe compared to a dummy medicine.
Poland · Spain · Czechia - recruitingNA
Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial
This study looks at whether a daily probiotic drink can help women aged 40-60 with skin issues like eczema or rosacea. We want to see if it can reduce inflammation and improve their immune system during menopause.
United Kingdom